New Key Statistics Module, Z-Score and F-Score
NAS:CORT Key Ratios
Market Cap $ M | 3,471.10 |
Enterprise Value $ M | 2,957.34 |
P/E(ttm) | 31.45 |
PE Ratio without NRI | 31.45 |
Forward PE Ratio | 46.68 |
Price/Book | 6.33 |
Price/Sales | 6.97 |
Price/Free Cash Flow | 29.48 |
Price/Owner Earnings | 43.89 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 523.00 |
EPS (TTM) $ | 1.06 |
Beneish M-Score | -2.01 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 5.40 |
y-y EBITDA Growth Rate % | 24.60 |
EV-to-EBIT | 24.25 |
EV-to-EBITDA | 23.92 |
PEG | 5.82 |
Shares Outstanding M | 104.11 |
Net Margin (%) | 22.54 |
Operating Margin % | 23.29 |
Pre-tax Margin (%) | 26.96 |
Quick Ratio | 5.10 |
Current Ratio | 5.18 |
ROA % (ttm) | 19.58 |
ROE % (ttm) | 23.92 |
ROIC % (ttm) | 69.46 |
Dividend Yield % | -- |
Altman Z-Score | 21.87 |
CORT Number of Guru Trades
CORT Volume of Guru Trades
Gurus Latest Trades with NAS:CORT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CORT is held by these investors
Total 2
Corcept Therapeutics Inc Insider Transactions
No Available Data
News about NAS:CORT
Total 0- 1